Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Nearly a quarter of all ovarian cancers are fueled by family genetics, so what should you do if your mom or sister ar ...

What is ovarian cancer? It's a cancer that strikes a woman's ovaries, the small almond-shaped organs that produce and release ...

Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival ...

Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated PatientsBoston (September 16, 2024) — Allarity ...

More than two decades later, their "One step closer to a Cure" race serves as Celma Mastry Ovarian Cancer Foundation’s ...

New research identifies specific genetic changes that can increase a person's risk of breast and ovarian cancers, to help guide clinical decision-making.